Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE)

RUSE is a retrospective data-based study designed to assess the frequency, characteristics and phenotype of documented recurrences of thromboembolic venous disease in atypical locations.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Venous Thromboembolism Cardiovascular Diseases Embolism and Thrombosis Thromboembolism Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Brest

Brest, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients over 18,
Affiliated to "sécurité sociale"
Having at least one episode of atypical localisation of VTE at Brest University Hospital

Exclusion criteria

Patients under legal protection
Minors
Refusal to participate

Treatment and study plan

Primary outcomes

Documented recurrence after previous VTE in atypical localisations

Time frame: 01/01/2005 to 01/11/2024

All forms of VTE of typical (DVT and PE) and atypical location, muscular venous thrombosis and documented superficial venous thrombosis

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Recurrence of Thromboembolic Venous Disease of Atypical Location

Acronym: RUSE

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Feb 10, 2025
Registry last updated: Feb 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting